A new virus emerges in rural China. Although those who contract it initially display moderate, flu-like symptoms, their health quickly declines. The mortality rate is unclear, but one aspect is immediately obvious—it’s very contagious. Within three months, nations around the world are planning lockdown protocols and quarantine measures. Politicians seem completely out of their league and ill-equipped. 

The world eventually recovers from the ordeal, but consequences of the virus linger for decades.While society pushes forward, there’s no promise that an even deadlier virus isn’t already lurking out of sight.

This isn’t about COVID-19, by the way. It’s the plot to the novel World War Z—arguably the most realistic depiction of a zombie apocalypse ever created. Released 20 years ago this week, the horror novel by Max Brooks quickly became one of the undisputed cornerstones of walking dead canon. Readers and critics devoured the book (no pun intended), but their responses often worry Brooks. Much like the reception to his first book, The Zombie Survival Guide, many fans seem to misunderstand his intentions. These projects weren’t simply intended to entertain. Max Brooks was trying to warn everyone about the looming threats we would prefer to ignore.

While the 54-year-old writer ostensibly writes books about zombies, Sasquatch, and (soon) an alien invasion, his attention to disaster details and hyperrealism has earned him a parallel career as a security and threat analyst for some of the world’s most respected geopolitical think tanks.

To celebrate World War Z’s 20th anniversary, Popular Science recently spoke with Brooks about the book’s massive impact.

This interview has been edited for length and clarity.

Andrew Paul: Did you anticipate World War Z attaining the legacy it now has in popular culture?

Max Brooks: Oh, God no. Of course not. Especially because I’m never tapped into pop culture. I don’t know what anybody else is doing—even when it was my job writing for Saturday Night Live! I’m good at thinking about what I think about.

AP: Before World War Z, you wrote an actual preparedness handbook called The Zombie Survival Guide. What prompted you to take a hyperreal approach to such a seemingly outlandish subject?

MB: The reason I wrote [them] was because all the zombie stories, even to this day, tend to focus around small groups. To me, it’s like trying to understand World War II from watching Saving Private Ryan. I had big picture questions nobody was answering.

I think the best zombie movie ever made was Dawn of the Dead. To me, the most interesting part was when they’re holed up in the mall watching the news. That window into the wider world was so fascinating, and I wanted more.

AP: But there was a time when World War Z almost never happened, right?

MB: [The publisher] didn’t know what to do with The Zombie Survival Guide. Their marketing strategy almost killed my career before it even launched. They thought, “Well, no one is clearly that much of a loser that he’s actually spent this much time thinking about [zombies]. Clearly, he’s a cool guy making fun of those losers. And because he’s Mel Brooks’ son and he’s coming off SNL, we’re gonna position him as Mel Brooks, Jr. writing Younger Frankenstein.”

But The Zombie Survival Guide really is a disaster preparedness manual. It’s why [soldiers] took it to Afghanistan; people told me it saved their lives when they were lost in the woods. I didn’t make anything up. It’s not Hollywood stuff—it’s all about dehydration and dry socks and shelter.

But [these books were] legitimately the product of years of thinking, “If I was in a zombie world, how would I survive?” It really set me on this path of asking, “What happens when the grown-ups drop the ball?”

AP: And now it’s your job to worry professionally.

MB: I’ve now been part of three military and national security think tanks—the Atlantic Council, the Center for Strategic and International Studies, and the Modern War Institute at West Point. I’m a non-resident senior fellow at all three of them, and it’s my job to study real threats.

For some reason, I was not blessed with the wall of denial. Like, I can’t just say, “That would never happen and I’m just going to go about my merry way.” I’m already terrified! And the way to reduce my anxiety is to study the threat so that it’s not nebulous.

AP: What was the most difficult part in preparing to write World War Z?

MB: You don’t know what you don’t know, so you don’t know what you’re missing. There’s always a fear of groping around in the dark; of not even knowing who to talk to. That was a real struggle, because I’m an insular guy. I’m not a social guy. Part of it was talking to experts, but part of it was reading books—and I’m fully dyslexic. So that was a real slog.

It was also about never trusting the internet. I used it once or twice, like, to research laser weaponry. I literally went to a company’s website, saw their demonstration video, and was like, “Yeah, okay. That is not a practical weapon for hunting zombies. I see how long it takes to burn through something.”

AP: Obviously humanity’s most terrifying challenge in the last 20 years was the COVID-19 pandemic. How do you view that real-world horror in the context of World War Z? 

MB: COVID was scary because I knew it was coming thanks to my friends in the military and biodefense community. I was part of what was called the Blue Ribbon Biodefense Panel for germ attacks way before COVID. So I already had at my fingertips the ability to tell the difference between panic porn in the media and the real deal. I also had to study diseases enough to write about a zombie plague. But also, it came from being on the receiving end of a bioterror attack. When I worked at SNL [from 2001 to 2003], we had the anthrax letters delivered to our building [in October 2001].

So, I knew this was coming, but the question was how to warn people. I had people laughing at me. Ironically, the people who are the worst minds to reach are the smarty-smarts because they think they know everything.

AP: Were you expecting COVID to be much worse than it was?

MB: Oh, much worse. It got me into trouble, because I was prepping for, like, tanks on the street, you know? I was ready for that. I stocked my home with food that would last the longest as opposed to food that my wife would actually eat. 

But the irony is, had it been worse, we might have actually done better. Studying diseases over the years—it’s sort of like the slow zombie versus the fast zombie. The fast zombie is so scary you have to react. The slow zombie gives you the false sense of security. Like, “Oh, I can take ‘em out.” COVID was the slow zombie. It allowed us to be arrogant and dismiss it: “Oh, it’s no worse than the flu.”

AP: How did you see that play out during the quarantine?

MB: It goes back to when COVID hit New York City. I had written a book called The Harlem Hellfighters, which was a true story of African American soldiers in World War I. They’re still an active unit in the National Guard, and I’m friends with their chief medical officer. Their job was to pick up the dead bodies around New York.

He said to me, “If those bodies had been stacked up on the street for everyone to see them, there would have been no argument about masking or distancing or taking the vaccine.” The hiding of it is what allowed naysayers to get way more people killed.

AP: Where did the grown-ups “drop the ball,” as you say?

MB: I think the greatest failure on the part of leadership at every level was not publicizing the dead. Maybe they were afraid of angry letters and backlash and didn’t want to cause a panic, but that’s exactly what they should have done.

A doctor in Los Angeles told me they converted hospital rooms into morgues. He said, “You don’t believe the amount of bodies. We’ve got pyramids of body bags.” And I’m like, “Well, then why is this not on the news every night?”

AP: After experiencing an actual global plague, how do you feel about World War Z’s overall accuracy?

MB: I think it was accurate for the time. I would still have the plague coming from China, 100 percent. I would love to say that was my genius futuristic prediction, but no. I based it on SARS. And this is why it’s unforgivable that it happened again. If I wrote it today, I would really highlight why it was allowed to be [downplayed]—and the reason is our greed. All of our stuff is made in China.

I would also really change the politicization of information. We’re living in a time where all facts have become tribalized. We’ve had 20 years of such dumbing down that I think it would be a central tenant of the book.

AP: Would you change how the United States responded to a zombie outbreak?

MB: I still firmly believe we are a moderate country, but I don’t know how brave we are. In order for a crime to be committed, you don’t need 100 bullies. You just need one bully and 99 cowards.

The psycho fanatics have a microphone now, which was inconceivable 20 years ago. They are hate merchants, and the erosion of our education system has created a demand that the merchants supply.

AP: So you think we would have handled COVID differently in 2006?

MB: If COVID happened 20 years earlier, we would all have gotten vaccinated, because of all the grandmas and grandpas who grew up before the polio vaccine.

AP: What else has changed?

MB: When I talk to people in power, I try to educate them about what I call “uphill influence” versus “downhill influence.” Downhill influence is when there’s a pre-existing bias that you just need to hijack and ride downhill. There’s gravity already there, and that’s not necessarily a bad thing. It was an established fact 20 or 30 years ago that vaccines kept you safe. So, if you were rolling out a vaccine, you could already just ride that existence acceptance downhill. The gravity was with you.

Uphill is when you have to educate before you can even start to persuade. You first have to educate people about just the world that you’re trying to explain. Vaccines have gone from downhill to uphill. The [subjects] we all had to try to stay awake through in seventh grade science class aren’t even there anymore.

I understand [MAHA supporters] want a clean planet, food, and water, and all of that will make you healthier. However, in 1491, the people who lived on this continent had all that, right? The moment the first Javier Bardem-looking Spaniard coughed on them, whole civilizations died.

AP: Both of your zombie books hinge on public education, and that’s now a major aspect of your threat analysis work. Do you know why you keep returning to this theme?

MB: I think one of the reasons I’m so obsessed with education is because I was not a good student. I have such ferocious learning disabilities. I never felt instantly comfortable learning, and I’ve always had to find workarounds. My mother had to help me find workarounds so I could learn. So when I research, it takes so much time and effort and [there’s] so much insecurity. I understand how hard it is to teach something to someone who doesn’t naturally pick it up.

I’m very lucky that I come from two parents who had no formal education, but were both very smart. Most importantly, they were very curious. I became very comfortable with the idea of approaching something as an absolute beginner.

AP: It took 14 years between World War Z and your follow-up sci-fi novel, Devolution. Your next book, The First Hundred Hours: A Story of Alien Invasion, comes out in 2027. Is there a reason for such long pauses between these projects?

MB: I’m not a natural scientist. The amount I’ve had to study for this new book has been excruciating. But it’s very humbling having to talk to the experts and say things like, “Please talk to me like I’m a third grader—and not a smart third grader.”

AP: Would you end World War Z the same if it was set in 2026?

MB: I would still end it on a positive note, and I think that has to do with being an American. We don’t have the luxury of abandoning our ideals, because that’s all we are. We’re not a nation-state—the ideals in America are all that hold this mutt [of a] nation together. We all come from different places and tribes, and we all agree to live under a certain set of guidelines. It’s really critical that we fight for those guidelines.

If there is one takeaway, it’s the central reason I wrote the book in the first place. We’re all stuck on the same planet together, and that planet is not that big anymore. What affects some of us could potentially affect all of us. I think America has some amazing cultural strengths, but one of our weaknesses is our isolationism. That’s built on an outdated notion that we are somehow protected by two oceans and our geography. That’s not true anymore.

The post Max Brooks reflects on 20 years of ‘World War Z’ appeared first on Popular Science.

Labor Day is in the rearview mirror, kids are back to school, and a squall of pumpkin spice is upon us. It's that time again to prepare for the equally inevitable respiratory virus season with annual vaccines.

With fervent anti-vaccine activist Robert F. Kennedy Jr. as the country's top health official, it might seem like the rollout of this year's shots could be a disaster. For instance, one of Kennedy's first actions as health secretary last year was to obliterate an ad campaign for flu shots amid a particularly deadly flu season. As we head into this fall, the Centers for Disease Control and Prevention's vaccine advisory committee—which normally sets vaccination recommendations and insurance coverage for the shots—is nonfunctioning. A federal judge ruled in March that the anti-vaccine allies Kennedy installed on the panel were illegally appointed and unfit to serve. All their changes to vaccine policy have been temporarily voided. And meanwhile, Kennedy spent last week trying to obscure the number of babies who died from measles so far this year (it was two, including a newborn).

Big picture

Despite all of that, the fall vaccine effort is looking like it will likely be somewhat smooth, potentially unremarkable even. The Food and Drug Administration has approved updated flu and COVID-19 shots for this season. Those shots have already begun arriving at pharmacies—in case your pharmacy hasn't already sent you multiple texts and reminders. While there are still some snags for access, it seems like it will be a lot like last year's fall vaccine rollout.

Read full article

Comments

Even years after the acute phase of the COVID-19 pandemic faded from daily headlines, one of its most stubborn legacies continues to shadow millions of working adults: post-COVID conditions, the cluster of persistent symptoms now broadly known as long COVID. A new cross-sectional study from Taiwan, published in BMC Psychology, offers a sobering snapshot of what these conditions mean for mental health and the capacity to work, even among people who were highly vaccinated and infected predominantly during the milder Omicron era. The findings challenge a lingering assumption that vaccination and less virulent variants have fully neutralized the long-term occupational and psychological costs of SARS-CoV-2 infection.

The research, led by Jhe-Ping Lin of the Department of Occupational Medicine at Linkou Chang Gung Memorial Hospital in Taoyuan City, together with Chia-Cheng Chang, Chen-Chang Yang, Ting-An Yang and corresponding author Yu-Chung Tsao, set out to answer a question that has become increasingly urgent for occupational health practitioners worldwide: how do employed adults who report persistent post-COVID symptoms differ, in measurable psychological and functional terms, from infected peers who consider themselves fully recovered? Much of the existing long COVID literature emerged from populations infected with earlier viral variants, before widespread vaccination, and focused heavily on physical sequelae. Relatively less is known about the psychological and occupational footprint of post-COVID conditions under contemporary epidemiological conditions, which is precisely the gap the Taiwanese team sought to fill.

The study design was straightforward but methodologically deliberate. Employed adults with prior confirmed SARS-CoV-2 infection were recruited through clinical and occupational-health channels using non-probability sampling, a practical approach for reaching workers with documented infection histories. All participants completed a battery of validated questionnaires assessing four core domains: health-related quality of life, fear of COVID-19, insomnia severity and work ability. The investigators then divided the cohort into two groups based on whether participants reported persistent symptoms consistent with post-COVID conditions, and statistically compared the two groups on every psychological and occupational measure. This symptom-based categorization mirrors the approach increasingly favored internationally, since no single laboratory biomarker can yet reliably define long COVID.

The results were striking in their consistency. Participants reporting post-COVID conditions demonstrated significantly lower quality of life, with a mean difference of 13.9 points on the quality-of-life instrument compared with fully recovered peers. They also scored higher on the Fear of COVID-19 Scale, a validated measure of pandemic-related anxiety, and reported greater insomnia severity, suggesting that disturbed sleep is a common companion of persistent post-viral illness. Perhaps most consequential for employers and policymakers, the post-COVID group showed reduced scores on the Work Ability Index, a well-established instrument that quantifies how well a worker perceives themselves able to meet the physical and mental demands of their job. The mean difference of 3.3 points on this index may sound modest, but in occupational medicine research, shifts of this magnitude on the Work Ability Index are considered clinically meaningful and are associated with elevated risks of reduced productivity, prolonged sickness absence and early exit from the labor force.

To appreciate why these numbers matter, it helps to understand what each instrument measures. Health-related quality-of-life scales capture how illness erodes daily functioning across physical, emotional and social dimensions; a 13.9-point deficit represents a substantial perceived deterioration in wellbeing, not a marginal statistical blip. The Fear of COVID-19 Scale taps illness-related anxiety that can itself become disabling, feeding avoidance behaviors and hypervigilance. Insomnia severity indices quantify difficulties falling asleep, staying asleep and feeling restored by sleep, and chronic insomnia is strongly linked to depression, impaired concentration and workplace accidents. The Work Ability Index synthesizes a worker’s self-assessed physical and mental capacity, diagnosed illnesses and resources relative to job demands, making it one of the most predictive single measures available for future work disability. That all four domains moved in the same negative direction among the post-COVID group paints a coherent picture of a population under compounding psychological and functional strain.

Crucially, these associations emerged within a population that reflects the current reality of the pandemic rather than its early, pre-vaccine chapter. Taiwan maintained exceptionally high vaccination coverage, and the overwhelming majority of infections in the study cohort occurred during the Omicron-dominant period, when the variant itself was generally associated with less severe acute disease. The persistence of measurable psychological and occupational burden under these comparatively favorable conditions suggests that the risk of long-term impairment has been reduced but not eliminated. For the millions of workers globally who have been infected with Omicron-lineage viruses despite vaccination, the Taiwanese data imply that lingering symptoms remain a genuine occupational health concern rather than a relic of earlier pandemic waves.

The authors are careful about what their study can and cannot claim. Because the design is cross-sectional, capturing participants at a single point in time, causal relationships cannot be inferred. It remains possible, for instance, that pre-existing anxiety, poor sleep or low work ability influenced how participants recalled and reported persistent symptoms, rather than the symptoms driving the psychological burden. The non-probability recruitment strategy, while effective for reaching the target population, also limits generalizability; workers who chose to participate in an occupational health study may differ systematically from those who did not. Self-reported symptom status, the standard for long COVID research given the absence of a definitive diagnostic test, introduces additional subjectivity. The researchers openly acknowledge these constraints and call for longitudinal studies to clarify recovery trajectories and functional outcomes over time, which would allow investigators to determine whether reduced work ability precedes, follows or merely co-occurs with post-COVID symptomatology.

Even with those caveats, the study carries practical implications that extend well beyond Taiwan. The authors argue that mental health assessment deserves a central place in post-COVID follow-up care, not as an afterthought but as a routine component of clinical evaluation. This recommendation aligns with a growing body of international evidence linking long COVID to depression, anxiety and sleep disorders, and it reframes post-COVID conditions as a psychosomatic and occupational problem in equal measure with a physical one. For occupational physicians, the message is that a worker presenting with persistent fatigue or brain fog should not only be evaluated for physical sequelae but also screened for insomnia, pandemic-related fear and diminished work capacity. For employers, the findings underscore the value of graded return-to-work programs, workplace accommodations and access to psychological support, since untreated mental health burdens may prolong functional impairment even after physical symptoms begin to subside.

The policy stakes are considerable. Post-COVID conditions affect a substantial fraction of infected individuals worldwide, and because the condition disproportionately impairs the ability to sustain full-time work, its economic ripple effects touch social insurance systems, disability programs and national productivity. Studies conducted in vaccinated, Omicron-era populations are especially valuable for forecasting the forward-looking burden, since they describe the risk profile relevant to new infections rather than historical ones. By demonstrating a 13.9-point quality-of-life deficit and a 3.3-point reduction in work ability under exactly these modern conditions, the Taiwanese study provides quantitative anchors that health economists and policymakers can use to model the ongoing costs of long COVID in the workforce.

The research also highlights the importance of studying long COVID outside the Europe-North America axis, where much of the literature has concentrated. Taiwan’s pandemic trajectory, characterized by early containment followed by a large, late Omicron wave in a highly vaccinated population, offers a distinct natural experiment. The fact that measurable occupational and psychological impairment still emerges in this setting strengthens the argument that post-COVID conditions are a global phenomenon requiring coordinated surveillance, standardized assessment tools and sustained investment in rehabilitation services. The study received no external funding and was approved by the Institutional Review Board of the Chang Gung Medical Foundation, with all participants providing informed consent under protocols compliant with the Declaration of Helsinki.

For now, the study’s central contribution is to quantify, with validated instruments, the invisible toll that persistent post-viral symptoms exact on working adults: poorer perceived health, greater fear, worse sleep and a weakened sense of capacity to meet job demands. As health systems worldwide transition from emergency response to long-term management of COVID-19’s aftermath, evidence of this kind, gathered under the most favorable epidemiological conditions yet seen, serves as a reminder that the pandemic’s occupational and psychological dimensions are far from over. The authors’ call for longitudinal follow-up is the natural next step, and its findings will help determine whether the burdens documented here fade with time or harden into chronic disability for a vulnerable segment of the working population.

Fauci privately put Covid's fatality rate at 0.2-0.3% then told Congress it was 10 times deadlier than flu. The 32 days between his diary entry and sworn testimony contain nearly the whole catastrophe, says Randall Bock.

The post Why Did Fauci Exaggerate the Threat From COVID-19? appeared first on The Daily Sceptic.

Source

Scientists who were instrumental in shutting down the Covid lab-leak theory admitted in private "we can’t rule it out" months after publishing a paper closing down the possibility, newly released messages show.

The post The Messages That Show Covid Scientists Secretly Suspected a Lab Leak appeared first on The Daily Sceptic.

La evidencia más sólida hasta ahora muestra que la vacunación frente a la covid-19 reduce de forma notable el riesgo de hospitalización materna y de parto prematuro, incluso frente a variantes como Delta u Ómicron, reforzando las recomendaciones sanitarias internacionales.

Durante buena parte de la pandemia, la vacunación en mujeres embarazadas fue objeto de debate público, dudas médicas y desinformación persistente. A pesar de que los organismos internacionales insistieron desde fases tempranas en la seguridad de las vacunas, la falta de grandes estudios específicos alimentó la incertidumbre. Ahora, una investigación canadiense de gran escala aporta datos concluyentes que cambian el tono de la discusión.

El trabajo, liderado por la University of British Columbia y realizado en el marco de la red nacional CANCOVID-Preg, analizó cerca de 20 000 embarazos a lo largo de distintas olas de la pandemia. Sus resultados muestran con claridad que las mujeres embarazadas vacunadas no solo desarrollaron formas menos graves de covid-19, sino que también tuvieron menos probabilidades de sufrir complicaciones obstétricas graves, incluidos los partos prematuros.

Un análisis sin precedentes en tamaño y alcance

El estudio se basó en datos recopilados entre abril de 2021 y diciembre de 2022, un periodo marcado por la circulación sucesiva de varias variantes del SARS-CoV-2. A diferencia de investigaciones previas, limitadas a una sola región o a una fase concreta de la pandemia, esta incluyó información de diez provincias canadienses y abarcó desde la ola de la variante Delta hasta la expansión de Ómicron y sus subvariantes.

Los investigadores compararon los desenlaces clínicos de mujeres embarazadas, vacunadas y no vacunadas que contrajeron la infección. Para garantizar resultados robustos, el análisis se ajustó por factores como la edad materna, el índice de masa corporal y la presencia de enfermedades previas, entre ellas diabetes gestacional o hipertensión. Este enfoque permitió aislar con mayor precisión el efecto de la vacunación.

Los hallazgos fueron publicados en JAMA, una de las revistas médicas más influyentes del mundo, lo que refuerza el peso científico del trabajo y su impacto en el ámbito de la obstetricia y la salud pública. El estudio también fue difundido por plataformas especializadas en comunicación científica como EurekAlert!, que adelantaron sus principales conclusiones a la comunidad médica internacional.

Menos hospitalizaciones y cuadros graves

Uno de los datos más contundentes del estudio es la reducción del riesgo de hospitalización entre las embarazadas vacunadas que se infectaron con el virus. Según el análisis, estas mujeres tuvieron alrededor de un 60 % menos de probabilidades de requerir ingreso hospitalario en comparación con las no vacunadas.

La diferencia fue todavía más marcada en los casos más graves. El riesgo de ingreso en unidades de cuidados intensivos se redujo en torno a un 90 % entre las mujeres que habían recibido al menos una dosis de la vacuna antes de la infección. Estas cifras se mantuvieron consistentes a lo largo de las distintas variantes analizadas, lo que sugiere un efecto protector sostenido de la inmunización.

La profesora Deborah Money, obstetra y ginecóloga de la University of British Columbia y autora principal del estudio, subrayó la solidez de los resultados al presentar los datos. “Nuestros resultados ofrecen una evidencia muy clara de que la vacunación contra la covid-19 protege a las mujeres embarazadas frente a las formas más graves de la enfermedad”, afirmó. “Esa protección se mantuvo incluso cuando el virus fue cambiando con el tiempo”.

Impacto directo en la salud del bebé

Más allá de los beneficios para la madre, el estudio aporta información clave sobre los efectos de la vacunación en los resultados neonatales. El parto prematuro, definido como aquel que ocurre antes de las 37 semanas de gestación, es uno de los principales factores de riesgo para la salud infantil a corto y largo plazo.

Los datos muestran que la vacunación se asoció a una reducción significativa de estos nacimientos prematuros. Durante la ola de la variante Delta, el riesgo disminuyó aproximadamente un 20 %, mientras que en el periodo dominado por Ómicron la reducción alcanzó cerca del 36 %. Esta diferencia entre variantes no se interpretó como una pérdida de eficacia, sino como un reflejo de las características clínicas distintas de cada cepa.

Además, el estudio no encontró un aumento del riesgo de resultados adversos poco frecuentes pero graves, como la muerte fetal. Por el contrario, los datos apuntan a que estos eventos fueron menos frecuentes entre las mujeres vacunadas, aunque los investigadores subrayan que se trata de desenlaces raros y que deben interpretarse con cautela.

Vacunarse durante el embarazo puede aportar un beneficio extra

Uno de los hallazgos más llamativos del trabajo fue la diferencia observada según el momento de la vacunación. Las mujeres que recibieron la vacuna durante el embarazo mostraron, en promedio, mejores resultados que aquellas que habían completado la pauta antes de quedarse embarazadas.

En este grupo, la incidencia de partos prematuros y de otros desenlaces adversos fue aún menor. Los investigadores plantean que la respuesta inmunitaria generada durante la gestación podría traducirse en una protección más directa tanto para la madre como para el feto, incluyendo la transferencia de anticuerpos a través de la placenta.

La epidemióloga Elisabeth McClymont, coautora del estudio, destacó este aspecto al explicar los resultados. “No existe un mal momento para vacunarse, ya sea antes o durante el embarazo”, señaló. “Pero nuestros datos sugieren que recibir la vacuna durante la gestación puede ofrecer una protección adicional frente a algunos riesgos obstétricos”.

Un respaldo clave para las políticas de salud pública

La publicación de estos resultados llega en un contexto internacional marcado por mensajes contradictorios sobre la vacunación. En algunos países, los cambios en las recomendaciones oficiales y el debate político han generado confusión, especialmente entre colectivos vulnerables como las mujeres embarazadas.

Frente a ese escenario, el estudio canadiense aporta una base científica sólida para sostener las recomendaciones vigentes en numerosos sistemas de salud. Organismos internacionales y autoridades sanitarias de distintos países mantienen el consejo de vacunar a las mujeres embarazadas contra la covid-19, basándose en la evaluación continua de la evidencia disponible.

Para Deborah Money, los datos no dejan margen a la ambigüedad. “La evidencia es abrumadora: la vacunación durante el embarazo es segura y eficaz”, afirmó. “Nuestro estudio proporciona información crucial tanto para las mujeres embarazadas como para los profesionales sanitarios que las atienden, y confirma que las políticas que recomiendan la vacunación van en la dirección correcta”.

Más allá de la covid-19

Los autores del estudio subrayan que sus conclusiones tienen implicaciones que trascienden la pandemia actual. Históricamente, las mujeres embarazadas han sido excluidas de muchos ensayos clínicos de vacunas y medicamentos, lo que ha generado lagunas de conocimiento precisamente en un grupo especialmente vulnerable.

La experiencia acumulada durante la pandemia demuestra, según los investigadores, que es posible y necesario generar evidencia de alta calidad sobre intervenciones preventivas en el embarazo. “Durante la gestación, tanto la madre como el bebé son especialmente sensibles a las infecciones respiratorias”, explicó McClymont. “Este trabajo muestra que la vacunación puede marcar una diferencia real y medible en su salud”.

El estudio canadiense se suma así a un cuerpo creciente de literatura científica que apoya la inclusión activa de mujeres embarazadas en estrategias de prevención y en la investigación clínica. En un debate que durante años estuvo dominado por la cautela y la falta de datos, los nuevos resultados aportan una claridad difícil de ignorar y refuerzan el mensaje central: proteger a la madre es también proteger al bebé.

In a groundbreaking controlled longitudinal study published this year, researcher T.A. Hooven has provided critical new insights into the often elusive and controversial phenomenon known as pediatric long COVID. This study, featured in Pediatric Research, offers a comprehensive and methodically rigorous examination of how SARS-CoV-2 infection impacts children over extended timeframes, revealing the nuanced and multifaceted nature of long COVID symptoms in this vulnerable demographic.

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has been largely characterized in adult populations, but pediatric cases have remained less well understood due to heterogeneous symptomatology and diagnostic challenges. Hooven’s study bridges this knowledge gap by employing a controlled design that meticulously tracks the clinical trajectory of infected children from the acute phase through many months of follow-up. This approach helps to clarify previously conflicting reports by delineating symptom patterns, persistence, and resolution with unprecedented clarity.

The longitudinal design of the study is foundational to extracting causative insights rather than relying on cross-sectional or anecdotal evidence. By enrolling a large pediatric cohort confirmed for SARS-CoV-2 infection alongside matched controls uninfected by the virus, the research controls for confounding variables such as preexisting health conditions, socio-demographic factors, and environmental influences. This design allows for robust comparisons and a more accurate attribution of observed clinical outcomes directly to COVID-19.

One of the study’s most compelling findings is the identification of specific symptom clusters that characterize pediatric long COVID. These include persistent fatigue, cognitive dysfunction often referred to as “brain fog,” intermittent fever, respiratory difficulties, and gastrointestinal disturbances lasting well beyond the acute illness phase. The persistence of these symptoms in a subset of children underscores the potential for COVID-19 to induce chronic systemic effects, perhaps mediated by ongoing immune dysregulation or viral persistence.

The neurology of pediatric long COVID emerges as a particularly striking aspect in Hooven’s research. Detailed neurocognitive testing and neuroimaging studies conducted at several time points revealed subtle yet significant impairments in memory, attention, and executive function among children diagnosed with long COVID compared to controls. These findings illuminate the brain as a critical organ affected by the post-viral syndrome and suggest mechanisms involving neuroinflammation or microvascular injury caused by the virus or the host immune response.

Immunologically, the study delves into the complex interplay between innate and adaptive immune responses in children during and after SARS-CoV-2 infection. The longitudinal immune profiling demonstrated prolonged elevations in inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which correlated with symptom severity. This immune signature supports theories that long COVID may be driven by sustained immune activation rather than simply persistent viral replication.

Importantly, Hooven’s controlled study also dissects the impact of viral variants and vaccination status on pediatric long COVID outcomes. Although vaccinated children showed reduced rates of long COVID symptoms, the study acknowledges breakthrough infections still pose a risk, albeit at significantly lower levels. Variants with altered spike proteins appeared to modulate symptomatology and severity, emphasizing the dynamic nature of the viral threat and the corresponding clinical repercussions.

Clinically, these findings have profound implications for diagnosis and management. The study advocates for the development of standardized diagnostic criteria tailored specifically for pediatric long COVID, incorporating objective biomarkers and functional assessments rather than solely symptom reporting. Moreover, Hooven highlights the necessity of multidisciplinary care models involving pediatricians, neurologists, immunologists, and rehabilitation specialists to address the complex needs of affected children comprehensively.

Another impactful element of the research concerns the psychosocial burden of long COVID on children and their families. Prolonged symptoms disrupt schooling, social interactions, and mental health, contributing to stress and anxiety. The study stresses early psychosocial interventions alongside medical treatment to mitigate these secondary effects and improve quality of life.

Methodologically, the study stands out by employing advanced bioinformatics techniques to analyze longitudinal data. Machine learning algorithms were utilized to predict long COVID risk based on early clinical and immunological markers, offering a potential pathway toward personalized prognostics and preemptive interventions. This computational approach represents a forward leap in epidemiological research, integrating big data with clinical medicine.

Hooven’s investigation also explores potential pathogenic mechanisms beyond immune dysregulation, including endothelial dysfunction, microclot formation, and autonomic nervous system imbalance. These mechanisms align with emerging hypotheses in adult long COVID research and highlight systemic vascular and neurological contributions to the syndrome in children.

The durability of symptoms observed raises critical questions about long-term consequences for pediatric patients as they transition into adolescence and adulthood. The authors call for continued longitudinal surveillance beyond the current study timeframe to assess potential chronic disability, organ damage, and cumulative developmental impacts. This emphasizes that pediatric long COVID is not merely an acute crisis but a possible chronic public health concern.

Public health policy implications stem directly from the study’s conclusions. Hooven underscores the urgent need for increased funding and resources dedicated to pediatric COVID research and long COVID clinics. Additionally, public health messaging must adapt to incorporate awareness of pediatric long COVID, promoting vaccination, early detection, and supportive care to mitigate its effects.

In sum, T.A. Hooven’s controlled longitudinal study marks a major advance in understanding pediatric long COVID. It combines clinical rigor, immunological insight, neurocognitive evaluation, and advanced analytics to paint a detailed picture of this multifaceted syndrome. The findings compel the medical and scientific communities to refine diagnostic frameworks, enhance therapeutic approaches, and prioritize multidisciplinary research to address this growing pediatric health challenge.

As the COVID-19 pandemic evolves, the knowledge gained from such studies will prove invaluable for safeguarding the health of children worldwide. Hooven’s methodical elucidation of pediatric long COVID contours thus represents a pivotal step toward unraveling the complexities of post-viral conditions, guiding both clinical practice and policy in the years ahead.

Subject of Research: Pediatric Long COVID

Article Title: A controlled longitudinal study clarifies the contours of pediatric long COVID

Article References:
Hooven, T.A. A controlled longitudinal study clarifies the contours of pediatric long COVID. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05224-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-026-05224-9

From Ebola to Nipah, the combined death toll since Covid is under 1,000 worldwide. So why the endless panic? Follow the money – pandemic fearmongering is a growth industry, says Dr David Bell.

The post Follow the Money: Pandemic Fearmongering is a Growth Industry appeared first on The Daily Sceptic.